Omschrijving
This book focuses on important decision points and evidence needed for making decisions at these points during the development of a new drug. It takes a holistic approach towards drug development by incorporating explicitly knowledge learned from the earlier part of the development and available historical information into decisions at later stages. In addition, the book shares lessons learned from several select examples published in the literature since the publication of the first edition. The second edition reiterates the need for making evidence-based Go/No Go decisions in drug development discussed in the first edition. It substantially expands several topics that have seen great advances since the publication of the first edition. The most noticeable additions include three adaptive
Kenmerken
| Artikelnummer | 9300000074522191 |
|---|---|
| EAN | 9783030797317 |
| Categorie | Digital Reading |
| Productgroep | Boeken |
| Segment | Textual/Printed/Reference Materials |
| Prijs Nederland | € 48,99 |
| Prijs België | € 48,99 |
| Verzendkosten NL | Gratis |
| Verzendkosten BE | Gratis |
| Levertijd Nederland | Morgen in huis |
| Levertijd België | Morgen in huis |
| Verkoper | Partner |
Springer Series in Pharmaceutical Statistics - Quantitative Decisions in Drug Development bestellen bij snelkeus
Koop Springer Series in Pharmaceutical Statistics - Quantitative Decisions in Drug Development van Onbekend online in de categorie Digital Reading. Prijs € 48,99, levering in Nederland · Morgen in huis.